col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


46 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Molecular Biology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Jun―23 Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity Alina P. Sergeeva, Phinikoula S. Katsamba, Junzhuo Liao, Jared M. Sampson, Fabiana Bahna, Seetha Mannepalli, et al. (+4)
2 [GO] 2023―Jun―16 Validation of X-ray Crystal Structure Ensemble Representations of SARS-CoV-2 Main Protease by Solution NMR Residual Dipolar Couplings Yang Shen, Angus J. Robertson, Ad Bax
3 [GO] 2023―Jun―03 The RNA interference effector protein Argonaute 2 functions as a restriction factor against SARS-CoV-2 Joaquin Lopez-Orozco, Nawell Fayad, Juveriya Qamar Khan, Alberto Felix-Lopez, Mohamed Elaish, Megha Rohamare, et al. (+6)
4 [GO] 2023―Feb―10 Selenoprotein S interacts with the replication and transcription complex of SARS-CoV-2 by binding nsp7 Farid Ghelichkhani, Fabio A. Gonzalez, Mariia A. Kapitonova data acquisition, Sharon Rozovsky
5 [GO] 2023―Jan―20 The Cytoplasmic Domain of the SARS-CoV-2 Envelope Protein Assembles into a β-Sheet Bundle in Lipid Bilayers Aurelio J. Dregni, Matthew J. McKay, Wahyu Surya, Maria Queralt-Martin, Joao Medeiros-Silva, Harrison K. Wang, et al. (+3)
6 [GO] 2023―Jan―20 Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex Xingyu Yin, Horia Popa, Anthony Stapon, Emilie Bouda, Miguel Garcia-Diaz
7 [GO] 2022―Dez―21 Variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, John Butler, Elisa Fadda, Max Crispin
8 [GO] 2022―Nov―24 Human 14-3-3 proteins site-selectively bind the mutational hotspot region of SARS-CoV-2 nucleoprotein modulating its phosphoregulation Kristina V. Tugaeva, Andrey A. Sysoev, Anna A. Kapitonova, Jake L. R. Smith, Phillip Zhu, Richard B. Cooley, et al. (+2)
9 [GO] 2022―Nov―02 Unmasking the conformational stability and inhibitor binding to SARS-CoV-2 main protease active site mutants and miniprecursor Andrey Kovalevsky, Leighton Coates, Daniel W. Kneller, Rodolfo Ghirlando, Annie Aniana, Nashaat T. Nashed, John M. Louis
10 [GO] 2022―Aug―19 Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants Isha M. Wilson, Meredith N. Frazier, Jian-Liang Li, Thomas A. Randall, Robin E. Stanley
11 [GO] 2022―Jul―16 Allosteric hotspots in the main protease of SARS-CoV-2 Léonie Strömich, Nan Wu, Mauricio Barahona, Sophia N. Yaliraki
12 [GO] 2022―Jul―15 Binding adaptation of GS-441524 diversifies macro domains and downregulate SARS-CoV-2 de-MARylation capacity Aikaterini C. Tsika, Angelo Gallo, Nikolaos K. Fourkiotis, Aikaterini I. Argyriou, Sridhar Sreeramulu, Frank Löhr, et al. (+11)
13 [GO] 2022―Jul―07 Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814 Jian Li, Cheng Lin, Xuelan Zhou, Fanglin Zhong, Pei Zeng, Peter J. McCormick, et al. (+2)
14 [GO] 2022―Jun―11 Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis? Sunil Nagpal, Nishal Kumar Pinna, Namrata Pant, Rohan Singh, Divyanshu Srivastava, Sharmila S. Mande
15 [GO] 2022―Mai―17 An electrostatically-steered conformational selection mechanism promotes SARS-CoV-2 Spike protein variation Marija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Pglm Rodrigues, Panagiotis L. Kastritis
16 [GO] 2022―Mai―07 Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain Casey Patrick, Vaibhav Upadhyay, Alexandra Lucas, Krishna M.G. Mallela
17 [GO] 2022―Apr―09 Development of monoclonal antibodies to detect for SARS-CoV-2 proteins Nawneet Mishra, Joan Teyra, Ruthmabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, et al. (+7)
18 [GO] 2022―Feb―28 SARS-CoV-2 nucleocapsid protein targets a conserved surface groove of the NTF2-like domain of G3BP1 Mahamaya Biswal, Jiuwei Lu, Jikui Song
19 [GO] 2022―Jan―03 Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development Xuesen Zhao, Danying Chen, Xinglin Li, Lauren Griffith, Jinhong Chang, Ping An, Ju-Tao Guo
20 [GO] 2021―Dez―13 Where all the roads meet? A crossover prespective on host factors regulating SARS-CoV-2 infection Sneh Lata, Ritu Mishra, Ravi P. Arya, Pooja Arora, Anismrita Lahon, Akhil C. Banerjea, Vikas Sood
21 [GO] 2021―Nov―12 Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen Andrey M. Grishin, Nataliya V. Dolgova, Shelby Landreth, Olivier Fisette, Ingrid J. Pickering, Graham N. George, et al. (+2)
22 [GO] 2021―Okt―28 Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble Akinori Kidera, Kei Moritsugu, Toru Ekimoto, Mitsunori Ikeguchi
23 [GO] 2021―Okt―28 Glycosylation and serological reactivity of an expression-enhanced SARS-CoV-2 viral spike mimetic Himanshi Chawla, Sian E. Jossi, Sian E. Faustini, Firdaus Samsudin, Joel D. Allen, Yasunori Watanabe, et al. (+8)
24 [GO] 2021―Okt―01 The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz
25 [GO] 2021―Sep―22 Mechanisms of Antiviral Immune Evasion of SARS-CoV-2 Daniel K Beyer, Adriana Forero
26 [GO] 2021―Sep―03 Inhibition of SARS-CoV-2 infection by human defensin HNP1 and retrocyclin RC-101 Elena Kudryashova, Ashley Zani, Geraldine Vilmen, Amit Sharma, Wuyuan Lu, Jacob S. Yount, Dmitri S. Kudryashov
27 [GO] 2021―Aug―23 An Adverse OutcomesApproach to Study theEffects of SARS-CoV-2 in 3D Organoid Models Amrita Basu, Annapurna Pamreddy, Pragya Singh, Kumar Sharma
28 [GO] 2021―Jul―28 Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations Shane Miersch, Zhijie Li, Reza Saberianfar, Mart Ustav, James Brett Case, Levi Blazer, et al. (+22)
29 [GO] 2021―Jul―14 Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies Jiahui Chen, Kaifu Gao, Rui Wang, Guo-Wei Wei
30 [GO] 2021―Jun―24 A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process G.D. Noske, A.M. Nakamura, V.O. Gawriljuk, R.S. Fernandes, G. M. A. Lima, H. V. D. Rosa, et al. (+9)
31 [GO] 2021―Jun―20 The inherent dynamics and interaction sites of the SARS-CoV-2 nucleocapsid N-terminal region Jasmina S. Redzic, Eunjeong Lee, Alexandra Born, Aaron Issaian, Morkos A. Henen, Parker Nichols, et al. (+5)
32 [GO] 2021―Jun―09 Can we AlphaFold our way out of the next pandemic? Matthew K. Higgins
33 [GO] 2021―Mai―21 Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants Charlie Laffeber, Kelly de Koning, Roland Kanaar, Joyce HG Lebbink
34 [GO] 2021―Mai―14 Structural modeling of the SARS-CoV-2 Spike/human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility Hin Hark Gan, Alan Twaddle, Benoit Marchand, Kristin C. Gunsalus
35 [GO] 2021―Apr―22 N-Terminal finger stabilizes the S1 pocket for the reversible feline drug GC376 in the SARS-CoV-2 Mpro dimer Elena Arutyunova, Muhammad Bashir Khan, Conrad Fischer, Jimmy Lu, Tess Lamer, Wayne Vuong, et al. (+6)
36 [GO] 2021―Apr―08 Structure-Based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2 Frederic A. Fellouse, Shane Miersch, Chao Chen, Stephen W. Michnick
37 [GO] 2021―Mrz―26 Engineered ultra-high affinity synthetic antibodies for SARS-CoV-2 neutralization and detection Tomasz Slezak, Anthony A. Kossiakoff
38 [GO] 2021―Mrz―20 Platforms for Personalized Polytherapeutics Discovery in COVID-19 Chris Hopkins, Chidinma Onweni, Victoria Zambito, DeLisa Fairweather, Kathryn McCormick, Ebihara Hideki, et al. (+3)
39 [GO] 2021―Mrz―19 SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2+ Alex L. Lai, Jack H. Freed
40 [GO] 2021―Feb―05 The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins Kristina V. Tugaeva, Dorothy E. D. P. Hawkins, Jake L. R. Smith, Oliver W. Bayfield, De-Sheng Ker, Andrey A. Sysoev, et al. (+3)
41 [GO] 2020―Dez―17 Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition Joel D. Allen, Yasunori Watanabe, Himanshi Chawla, Maddy L. Newby, Max Crispin
42 [GO] 2020―Dez―11 The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition Takamitsu Hattori, Akiko Koide, Maria G. Noval, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng, et al. (+4)
43 [GO] 2020―Nov―24 Structural insights into SARS-CoV-2 proteins Rimanshee Arya, Shweta Kumari, Bharati Pandey, Hiral Mistry, Subhash C Bihani, Amit Das, et al. (+4)
44 [GO] 2020―Sep―11 Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot Krishna Neupane, Sneha Munshi, Meng Zhao, Dustin B. Ritchie, Sandaru M. Ileperuma, Michael T. Woodside
45 [GO] 2020―Jul―23 Mutations Strengthened SARS-CoV-2 Infectivity Jiahui Chen, Rui Wang, Menglun Wang, Guo-Wei Wei
46 [GO] 2020―Apr―19 Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop Javier A. Jaimes, Nicole M. André, Joshua S. Chappie, Jean K. Millet, Gary R. Whittaker
 [1] 

46 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.012 sec